This revealed that the stromal co-expression of PEAK1 and SNAI2 was significantly increased in HER2-positive tumor tissues (n = 79) (Fig. 1i–k and Supplementary Fig. 2b). This evidence concerns the gene ERBB2 and neoplasm.